In the Phase 3 of the clinical trials conducted by GW Pharmaceuticals and the Ohio State University on the effectiveness of Epidiolex, results showed that the cannabis-based drug lowered the number of epileptic seizures experienced by children with Lennox-Gastaut syndrome by half.
What Is Lennox-Gastaut Syndrome?
The Lennox-Gastaut syndrome is one of the rare forms of epilepsy, where the patient has different types of seizures, which can last anywhere from a few seconds to a few minutes. These seizures often are drop attacks where the person falls to because the body loses muscle tone. Aside from genetics, doctors believe that the condition can be caused when there are brain injuries during birth or brain infections.
The trial observed 225 teens around the age of 16 for a period of 14 weeks. The study group was composed of people who averaged 85 drop seizures